Determining the Safety of L-serine in ALS
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01835782 |
Recruitment Status : Unknown
Verified July 2015 by Phoenix Neurological Associates, LTD.
Recruitment status was: Active, not recruiting
First Posted : April 19, 2013
Last Update Posted : July 30, 2015
|
Sponsor:
Phoenix Neurological Associates, LTD
Collaborator:
Institute for Ethnomedicine
Information provided by (Responsible Party):
Phoenix Neurological Associates, LTD
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet
publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending
Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during
QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review
assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific
validity or relevance of the submitted information.
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | December 2016 |
Study Completion Date : | No date given |
Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
---|---|---|
1 |
October 5, 2017 | November 2, 2017 |